Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Cue Health's COVID-19 self-test approved in Singapore » 09:19
12/01/21
12/01
09:19
12/01/21
09:19
HLTH

Cue Health

$11.23 /

+0.11 (+0.99%)

, OMCL

Omnicell

$177.11 /

-0.06 (-0.03%)

Cue Health received…

Cue Health received Pandemic Special Access Route authorization from the Health Sciences Authority for the Cue COVID-19 Test for self-testing in Singapore. The Cue COVID-19 Test is the first natively digital molecular diagnostic product ever authorized for consumer home use in Singapore. Cue's partnership with Omnicell (OMCL) allows Cue to immediately begin supporting public sector use of the Cue COVID-19 Test. Cue intends to explore both public and private sector partnerships that Cue believes will further enable the complete utilization of the Cue Health Monitoring System for not only the Cue COVID-19 Test, but also Cue's future test menu and other offerings.

ShowHide Related Items >><<
OMCL Omnicell
$177.11 /

-0.06 (-0.03%)

HLTH Cue Health
$11.23 /

+0.11 (+0.99%)

HLTH Cue Health
$11.23 /

+0.11 (+0.99%)

10/19/21
Fly Intel: Top five analyst initiations
10/19/21 BTIG
Cue Health initiated with a Buy at BTIG
10/19/21 Cowen
Cue Health initiated with an Outperform at Cowen
10/19/21 Morgan Stanley
Cue Health initiated with an Equal Weight at Morgan Stanley
OMCL Omnicell
$177.11 /

-0.06 (-0.03%)

12/01/21 BTIG
Omnicell price target raised to $220 from $210 at BTIG
11/03/21 Craig-Hallum
Omnicell price target raised to $205 from $170 at Craig-Hallum
11/03/21 Piper Sandler
Omnicell price target raised to $211 from $188 at Piper Sandler
10/26/21 BTIG
Omnicell price target raised to $200 from $175 at BTIG
OMCL Omnicell
$177.11 /

-0.06 (-0.03%)

HLTH Cue Health
$11.23 /

+0.11 (+0.99%)

  • 24
    Sep
HLTH Cue Health
$11.23 /

+0.11 (+0.99%)

HLTH Cue Health
$11.23 /

+0.11 (+0.99%)

Tuesday
Conference/Events
Cue Health management to meet virtually with BTIG » 12:08
11/30/21
11/30
12:08
11/30/21
12:08
HLTH

Cue Health

$10.85 /

-0.27 (-2.43%)

Virtual Meeting to be…

Virtual Meeting to be held on December 7 hosted by BTIG.

ShowHide Related Items >><<
HLTH Cue Health
$10.85 /

-0.27 (-2.43%)

HLTH Cue Health
$10.85 /

-0.27 (-2.43%)

10/19/21
Fly Intel: Top five analyst initiations
10/19/21 BTIG
Cue Health initiated with a Buy at BTIG
10/19/21 Cowen
Cue Health initiated with an Outperform at Cowen
10/19/21 Morgan Stanley
Cue Health initiated with an Equal Weight at Morgan Stanley
HLTH Cue Health
$10.85 /

-0.27 (-2.43%)

  • 24
    Sep
HLTH Cue Health
$10.85 /

-0.27 (-2.43%)

HLTH Cue Health
$10.85 /

-0.27 (-2.43%)

Monday
Hot Stocks
Cue Health confirms COVID-19 tests can detect Omicron variant » 09:16
11/29/21
11/29
09:16
11/29/21
09:16
HLTH

Cue Health

$11.47 /

+1.445 (+14.41%)

Cue Health announced it…

Cue Health announced it has completed an analysis of the SARS-CoV-2 B.1.1.529 variant, designated by the World Health Organization as Omicron. Using information from the GISAID database, Cue has determined its COVID-19 tests, which uses molecular, NAAT, technology, can detect the Omicron variant. Specifically, Cue found that 99.2% of the available 127 published sequences are a perfect match to the primers used in the Company's tests. "Our molecular test is backed by the science and technology necessary to detect emerging variants, including Omicron, enabling individuals and healthcare practitioners to make better-informed decisions," said Ayub Khattak, Co-Founder and CEO of Cue. "Fast and accurate testing that is bolstered by a scientist-led surveillance and monitoring system, which identifies and analyzes variants in real time, will continue to play a critical role in producing actionable health data, preventing community spread and driving better outcomes."

ShowHide Related Items >><<
HLTH Cue Health
$11.47 /

+1.445 (+14.41%)

HLTH Cue Health
$11.47 /

+1.445 (+14.41%)

10/19/21
Fly Intel: Top five analyst initiations
10/19/21 BTIG
Cue Health initiated with a Buy at BTIG
10/19/21 Cowen
Cue Health initiated with an Outperform at Cowen
10/19/21 Morgan Stanley
Cue Health initiated with an Equal Weight at Morgan Stanley
HLTH Cue Health
$11.47 /

+1.445 (+14.41%)

  • 24
    Sep
HLTH Cue Health
$11.47 /

+1.445 (+14.41%)

HLTH Cue Health
$11.47 /

+1.445 (+14.41%)

Over a week ago
Hot Stocks
Cue Health and Helix partner for COVID-19 variant information solution » 09:20
11/18/21
11/18
09:20
11/18/21
09:20
HLTH

Cue Health

$12.72 /

-0.4 (-3.05%)

Cue Health and Helix, a…

Cue Health and Helix, a genomics company that provides nationwide viral surveillance of respiratory disease, announced a new collaboration to provide individuals who test positive on Cue's at-home molecular COVID-19 test the opportunity to learn which variant they have contracted as part of a broader research study on the SARS-CoV-2 virus. This collaboration builds on Cue's real-time Variant Tracking and Sequencing Platform, which will utilize AI and ML from Google Cloud. Cue Health and Helix intend to roll out this new capability in Q4. Cue users who receive a positive test result for COVID-19 will be able to opt-in to SARS-CoV-2 variant sequencing. Users will receive a same-day sample collection kit with a prepaid return shipper via Cue's last-mile delivery partners. The Cue Health App will guide users through a swab self-collection to obtain their sample for sequencing. Returned samples will arrive at Helix for processing, and results from Helix will be shared with the individual through the Cue Health App within ten days.

ShowHide Related Items >><<
HLTH Cue Health
$12.72 /

-0.4 (-3.05%)

HLTH Cue Health
$12.72 /

-0.4 (-3.05%)

10/19/21
Fly Intel: Top five analyst initiations
10/19/21 BTIG
Cue Health initiated with a Buy at BTIG
10/19/21 Cowen
Cue Health initiated with an Outperform at Cowen
10/19/21 Morgan Stanley
Cue Health initiated with an Equal Weight at Morgan Stanley
HLTH Cue Health
$12.72 /

-0.4 (-3.05%)

  • 24
    Sep
HLTH Cue Health
$12.72 /

-0.4 (-3.05%)

HLTH Cue Health
$12.72 /

-0.4 (-3.05%)

Earnings
Cue Health sees FY21 revenue $580M-$590M, consensus $541.29M  16:03
11/10/21
11/10
16:03
11/10/21
16:03
HLTH

Cue Health

$10.90 /

+0.52 (+5.01%)

 
ShowHide Related Items >><<
HLTH Cue Health
$10.90 /

+0.52 (+5.01%)

HLTH Cue Health
$10.90 /

+0.52 (+5.01%)

10/19/21
Fly Intel: Top five analyst initiations
10/19/21 BTIG
Cue Health initiated with a Buy at BTIG
10/19/21 Cowen
Cue Health initiated with an Outperform at Cowen
10/19/21 Morgan Stanley
Cue Health initiated with an Equal Weight at Morgan Stanley
HLTH Cue Health
$10.90 /

+0.52 (+5.01%)

  • 24
    Sep
HLTH Cue Health
$10.90 /

+0.52 (+5.01%)

HLTH Cue Health
$10.90 /

+0.52 (+5.01%)

Earnings
Cue Health reports Q3 EPS 14c vs (52c) last year » 16:03
11/10/21
11/10
16:03
11/10/21
16:03
HLTH

Cue Health

$10.90 /

+0.52 (+5.01%)

Reports Q3 revenue…

Reports Q3 revenue $223.7M, consensus $200.3M. "In the last few months, we generated record quarterly revenue while entering the public markets, growing our customer base, readying to launch our direct-to-consumer offering with integrated virtual care and in-app travel proctoring, and expanding our team," said Ayub Khattak, CEO and co-founder of Cue Health. "We're confident we've laid a solid foundation for long-term value creation at Cue and look forward to delivering on our mission of empowering people to live their healthiest lives through personalized, proactive, and informed healthcare."

ShowHide Related Items >><<
HLTH Cue Health
$10.90 /

+0.52 (+5.01%)

HLTH Cue Health
$10.90 /

+0.52 (+5.01%)

10/19/21
Fly Intel: Top five analyst initiations
10/19/21 BTIG
Cue Health initiated with a Buy at BTIG
10/19/21 Cowen
Cue Health initiated with an Outperform at Cowen
10/19/21 Morgan Stanley
Cue Health initiated with an Equal Weight at Morgan Stanley
  • 24
    Sep
HLTH Cue Health
$10.90 /

+0.52 (+5.01%)

HLTH Cue Health
$10.90 /

+0.52 (+5.01%)

Over a month ago
Hot Stocks
Cue Health provides molecular COVID-19 testing to MLB Clubs » 09:16
11/01/21
11/01
09:16
11/01/21
09:16
HLTH

Cue Health

$9.24 /

-0.53 (-5.42%)

Cue Health and Major…

Cue Health and Major League Baseball announced that Cue has been providing all Clubs, as well as the league office, with its integrated Cue platform, which features both the portable Cue Health Monitoring System and easy-to-use Cue COVID-19 tests, throughout the Postseason and World Series. The Cue COVID-19 Test for Home and Over The Counter Use is the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without physician supervision or a prescription. Cue's platform is a molecular diagnostic system that delivers results directly to mobile smart devices - both Android and iOS - in about 20 minutes.

ShowHide Related Items >><<
HLTH Cue Health
$9.24 /

-0.53 (-5.42%)

HLTH Cue Health
$9.24 /

-0.53 (-5.42%)

10/19/21
Fly Intel: Top five analyst initiations
10/19/21 BTIG
Cue Health initiated with a Buy at BTIG
10/19/21 Cowen
Cue Health initiated with an Outperform at Cowen
10/19/21 Morgan Stanley
Cue Health initiated with an Equal Weight at Morgan Stanley
  • 24
    Sep
HLTH Cue Health
$9.24 /

-0.53 (-5.42%)

HLTH Cue Health
$9.24 /

-0.53 (-5.42%)

Initiation
Fly Intel: Top five analyst initiations » 09:54
10/19/21
10/19
09:54
10/19/21
09:54
CWAN

Clearwater Analytics

$25.48 /

+0.29 (+1.15%)

, HLTH

Cue Health

$10.21 /

+0.2 (+2.00%)

, PENN

Penn National

$79.80 /

+2.49 (+3.22%)

, FUTU

Futu Holdings

$67.80 /

+3.89 (+6.09%)

, SRT

StarTek

$5.64 /

+ (+0.00%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Clearwater Analytics (CWAN) initiated with an Outperform at RBC Capital, William Blair, Credit Suisse, and Oppenheimer, initiated with an Overweight at JPMorgan and Wells Fargo, initiated with a Neutral at Goldman Sachs and Piper Sandler, initiated with an Equal Weight at Morgan Stanley and a Hold at Loop Capital. 2. Cue Health (HLTH) initiated with a Buy at Goldman Sachs, an Outperform at Cowen and an Equal Weight at Morgan Stanley. 3. Penn National (PENN) initiated with a Buy at Berenberg. 4. Futu Holdings (FUTU) initiated with a Buy at CLSA. 5. StarTek (SRT) initiated with an Outperform at Barrington. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
SRT StarTek
$5.64 /

+ (+0.00%)

PENN Penn National
$79.80 /

+2.49 (+3.22%)

HLTH Cue Health
$10.21 /

+0.2 (+2.00%)

FUTU Futu Holdings
$67.80 /

+3.89 (+6.09%)

CWAN Clearwater Analytics
$25.48 /

+0.29 (+1.15%)

10/19/21 Loop Capital
Clearwater Analytics initiated with a Hold at Loop Capital
10/19/21 Morgan Stanley
Clearwater Analytics initiated with an Equal Weight at Morgan Stanley
10/19/21 JPMorgan
JPMorgan starts Clearwater Analytics at buy on 'long runway' of growth
10/19/21 Wells Fargo
Wells Fargo bullish on Clearwater Analytics, initiates with an Overweight
HLTH Cue Health
$10.21 /

+0.2 (+2.00%)

10/19/21 BTIG
Cue Health initiated with a Buy at BTIG
10/19/21 Cowen
Cue Health initiated with an Outperform at Cowen
10/19/21 Morgan Stanley
Cue Health initiated with an Equal Weight at Morgan Stanley
10/19/21 Cowen
Cue Health initiated with an Outperform at Cowen
PENN Penn National
$79.80 /

+2.49 (+3.22%)

10/19/21 Berenberg
Berenberg starts Penn National at Buy with $95 price target
10/19/21 Berenberg
Penn National initiated with a Buy at Berenberg
10/15/21 JPMorgan
Penn National valuation 'undemanding' after underperformance, says JPMorgan
10/12/21
Fly Intel: Top five analyst initiations
FUTU Futu Holdings
$67.80 /

+3.89 (+6.09%)

10/19/21
Futu Holdings initiated with a Buy at CLSA
10/18/21 JPMorgan
Futu Holdings initiated with an Overweight at JPMorgan
10/15/21 BofA
BofA double downgrades Futu to Underperform on rising regulatory uncertainties
10/15/21 BofA
Futu Holdings downgraded to Underperform from Buy at BofA
SRT StarTek
$5.64 /

+ (+0.00%)

10/19/21 Barrington
StarTek initiated with an Outperform at Barrington
03/16/21 B. Riley
StarTek price target raised to $12 from $10.50 at B. Riley Securities
03/10/21 B. Riley
StarTek price target raised to $10.50 from $9 at B. Riley Securities
PENN Penn National
$79.80 /

+2.49 (+3.22%)

  • 24
    Sep
  • 24
    Sep
  • 21
    Apr
PENN Penn National
$79.80 /

+2.49 (+3.22%)

CWAN Clearwater Analytics
$25.48 /

+0.29 (+1.15%)

PENN Penn National
$79.80 /

+2.49 (+3.22%)

HLTH Cue Health
$10.21 /

+0.2 (+2.00%)

FUTU Futu Holdings
$67.80 /

+3.89 (+6.09%)

CWAN Clearwater Analytics
$25.48 /

+0.29 (+1.15%)

PENN Penn National
$79.80 /

+2.49 (+3.22%)

HLTH Cue Health
$10.21 /

+0.2 (+2.00%)

FUTU Futu Holdings
$67.80 /

+3.89 (+6.09%)

Initiation
Cue Health initiated with a Buy at BTIG » 09:30
10/19/21
10/19
09:30
10/19/21
09:30
HLTH

Cue Health

$10.01 /

-0.68 (-6.36%)

BTIG analyst Mark Massaro…

BTIG analyst Mark Massaro initiated coverage of Cue Health with a Buy rating and $18 price target. The analyst views Cue as a "rapidly growing" health technology platform company that is well positioned to take share both from reference labs, other point-of-care testing companies, and help expand the $80B U.S. lab testing market. He highlights its "industry-leading" handheld instrument form-factor, which the analyst says drives "much better" ease of use, particularly when used in people's homes.

ShowHide Related Items >><<
HLTH Cue Health
$10.01 /

-0.68 (-6.36%)

HLTH Cue Health
$10.01 /

-0.68 (-6.36%)

10/19/21 Cowen
Cue Health initiated with an Outperform at Cowen
10/19/21 Morgan Stanley
Cue Health initiated with an Equal Weight at Morgan Stanley
10/19/21 Cowen
Cue Health initiated with an Outperform at Cowen
10/19/21 Goldman Sachs
Cue Health initiated with a Buy at Goldman Sachs
  • 24
    Sep
HLTH Cue Health
$10.01 /

-0.68 (-6.36%)

HLTH Cue Health
$10.01 /

-0.68 (-6.36%)

Initiation
Cue Health initiated with an Outperform at Cowen » 08:56
10/19/21
10/19
08:56
10/19/21
08:56
HLTH

Cue Health

$10.01 /

-0.68 (-6.36%)

As reported previously,…

As reported previously, Cowen analyst Charles Rhyee initiated coverage of Cue Health with an Outperform rating and $14 price target. The analyst said the company offers an innovative testing system that provides the convenience of a consumer electronic device with the accuracy of complex molecular testing platforms, w/ the potential to disrupt the existing diagnostic testing market.

ShowHide Related Items >><<
HLTH Cue Health
$10.01 /

-0.68 (-6.36%)

HLTH Cue Health
$10.01 /

-0.68 (-6.36%)

10/19/21 Morgan Stanley
Cue Health initiated with an Equal Weight at Morgan Stanley
10/19/21 Cowen
Cue Health initiated with an Outperform at Cowen
10/19/21 Goldman Sachs
Cue Health initiated with a Buy at Goldman Sachs
  • 24
    Sep
HLTH Cue Health
$10.01 /

-0.68 (-6.36%)

HLTH Cue Health
$10.01 /

-0.68 (-6.36%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.